Form 4 BIODELIVERY SCIENCES For: Aug 07 Filed by: Broadfin Capital, LLC Aug 11, 2020 05:17PM
BioDelivery Sciences (BDSI) Appoints Jeff Bailey Interim CEO May 11, 2020 08:33AM
BioDelivery Sciences Appoints Jeff Bailey Interim CEO May 11, 2020 08:30AM
Form 4 BIODELIVERY SCIENCES For: Mar 17 Filed by: Broadfin Capital, LLC Mar 19, 2020 05:45PM
Form SC 13D/A BIODELIVERY SCIENCES Filed by: Broadfin Capital, LLC Dec 23, 2019 05:28PM


Dec 20, 2019 07:51PM Form 4 BIODELIVERY SCIENCES For: Dec 18 Filed by: Broadfin Capital, LLC
May 14, 2019 04:59PM Form 4 BIODELIVERY SCIENCES For: May 10 Filed by: Broadfin Capital, LLC
Apr 15, 2019 04:15PM Form 4 BIODELIVERY SCIENCES For: Apr 11 Filed by: Broadfin Capital, LLC
Dec 11, 2018 08:31AM Avadel Pharma (AVDL) Announces Kevin Kotler to Board
Dec 11, 2018 08:30AM Avadel Pharmaceuticals Appoints Kevin Kotler to the Company’s Board of Directors
Aug 8, 2018 05:12PM Form SC 13D/A BIODELIVERY SCIENCES Filed by: Broadfin Capital, LLC
May 23, 2018 07:33PM Form 3 BIODELIVERY SCIENCES For: May 21 Filed by: Broadfin Capital, LLC
May 22, 2018 08:30AM BioDelivery Sciences (BDSI) Names Peter Greenleaf as Chairman; Closes $50 Million Equity Financing
May 22, 2018 08:29AM BioDelivery Sciences Announces Closing of $50 Million Equity Financing and Appointment of Peter Greenleaf as Chairman of the Board
May 22, 2018 08:29AM BioDelivery Sciences Announces Closing of $50 Million Equity Financing and Appointment of Peter Greenleaf as Chairman of the Board
May 21, 2018 05:34PM Form SC 13D/A BIODELIVERY SCIENCES Filed by: Broadfin Capital, LLC
May 17, 2018 09:22AM Pre-Open Movers 05/17: (WWE) (LOXO) (NTES) Higher; (JNCE) (JCP) (ACXM) Lower (more...)
May 17, 2018 08:09AM BioDelivery Sciences (BDSI) Reports Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business
May 17, 2018 08:01AM BioDelivery Sciences Announces Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business
May 17, 2018 08:01AM BioDelivery Sciences Announces Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business
May 3, 2018 09:01AM BioDelivery Sciences Confirms Receipt of Notice of Intent to Nominate Directors by Broadfin Capital
May 1, 2018 08:43AM Form SC 13D/A BIODELIVERY SCIENCES Filed by: Broadfin Capital, LLC
Apr 10, 2018 06:03AM Form SC 13D BIODELIVERY SCIENCES Filed by: Broadfin Capital, LLC
Feb 13, 2018 04:33PM Form SC 13G/A BIODELIVERY SCIENCES Filed by: Broadfin Capital, LLC
Feb 13, 2017 12:53PM Form SC 13G/A BIODELIVERY SCIENCES Filed by: Broadfin Capital, LLC
Feb 12, 2016 04:43PM Form SC 13G/A BIODELIVERY SCIENCES Filed by: Broadfin Capital, LLC
May 20, 2015 05:13PM Broadfin Capital Raises Stake in BioDelivery Sciences (BDSI) to 7.3%
May 20, 2015 05:09PM Form SC 13G BIODELIVERY SCIENCES Filed by: Broadfin Capital, LLC
Feb 17, 2015 12:45PM Form SC 13G/A BIODELIVERY SCIENCES Filed by: Broadfin Capital, LLC